MGX
Price
$1.38
Change
+$0.12 (+9.52%)
Updated
Apr 4, 02:44 PM (EDT)
Capitalization
47.66M
46 days until earnings call
VERV
Price
$3.61
Change
-$0.24 (-6.23%)
Updated
Apr 4, 02:56 PM (EDT)
Capitalization
341.86M
33 days until earnings call
Ad is loading...

MGX vs VERV

Header iconMGX vs VERV Comparison
Open Charts MGX vs VERVBanner chart's image
Metagenomi
Price$1.38
Change+$0.12 (+9.52%)
Volume$2.43K
Capitalization47.66M
Verve Therapeutics
Price$3.61
Change-$0.24 (-6.23%)
Volume$1.61K
Capitalization341.86M
MGX vs VERV Comparison Chart
Loading...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGX vs. VERV commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGX is a StrongBuy and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (MGX: $1.26 vs. VERV: $3.85)
Brand notoriety: MGX and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGX: 84% vs. VERV: 182%
Market capitalization -- MGX: $47.66M vs. VERV: $341.86M
MGX [@Biotechnology] is valued at $47.66M. VERV’s [@Biotechnology] market capitalization is $341.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGX’s FA Score shows that 1 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • MGX’s FA Score: 1 green, 4 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, both MGX and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGX’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • MGX’s TA Score: 3 bullish, 4 bearish.
  • VERV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than MGX.

Price Growth

MGX (@Biotechnology) experienced а -18.18% price change this week, while VERV (@Biotechnology) price change was -27.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.31%. For the same industry, the average monthly price growth was -17.16%, and the average quarterly price growth was -18.95%.

Reported Earning Dates

MGX is expected to report earnings on May 20, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-11.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($342M) has a higher market cap than MGX($47.7M). VERV YTD gains are higher at: -31.826 vs. MGX (-65.097). MGX has higher annual earnings (EBITDA): -65.06M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. MGX (275M). MGX has less debt than VERV: MGX (46.1M) vs VERV (70M). MGX has higher revenues than VERV: MGX (55.1M) vs VERV (32.3M).
MGXVERVMGX / VERV
Capitalization47.7M342M14%
EBITDA-65.06M-221.91M29%
Gain YTD-65.097-31.826205%
P/E RatioN/AN/A-
Revenue55.1M32.3M171%
Total Cash275M524M52%
Total Debt46.1M70M66%
TECHNICAL ANALYSIS
Technical Analysis
MGXVERV
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYIAX117.89N/A
N/A
Rydex Internet H
BUFDX31.88N/A
N/A
Buffalo Growth & Income
JEEIX16.06N/A
N/A
JHancock Infrastructure I
VGIFX85.38N/A
N/A
JPMorgan US Value R5
WSMRX25.49N/A
N/A
William Blair Small-Mid Cap Growth R6

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
-5.26%
KOD - MGX
40%
Loosely correlated
-10.11%
CVM - MGX
37%
Loosely correlated
-5.47%
VERV - MGX
35%
Loosely correlated
-1.66%
IMNM - MGX
32%
Poorly correlated
-7.00%
CDXS - MGX
32%
Poorly correlated
-8.03%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-1.66%
CRSP - VERV
54%
Loosely correlated
-4.47%
BEAM - VERV
52%
Loosely correlated
-10.93%
RXRX - VERV
50%
Loosely correlated
-9.07%
NTLA - VERV
46%
Loosely correlated
-5.62%
IVEVF - VERV
46%
Loosely correlated
N/A
More